Hadar Amartely

Title: Hadar Amartely: Innovator in Biological Filtering Technologies

Introduction

Hadar Amartely is a notable inventor based in Ma'ale Adumim, Israel. He has made significant contributions to the field of biological filtering technologies, particularly in the context of medical applications. His work focuses on developing innovative solutions for the removal of pathogenic cells from biological fluids.

Latest Patents

Hadar Amartely holds a patent for a "Filter for removal of multiple sclerosis-associated t-cells." This invention describes biological filters designed to remove target components from biological fluids, such as the removal of pathogenic cells from whole blood. The filters include a medium with an inert surface, featuring capture material that allows for the selective recognition, capture, and removal of target cells associated with diseases, including autoimmune diseases and cancer. The patent encompasses devices, systems, apparatuses, computer-readable media, and methods related to biological filtering.

Career Highlights

Hadar Amartely is associated with Bioimmunate Technologies Ltd., where he continues to advance his research and development efforts. His innovative approach to biological filtering has the potential to significantly impact the treatment of various diseases.

Collaborations

Hadar collaborates with talented individuals in his field, including Sigalit Carmel and Shimon Shteingart. Their combined expertise contributes to the ongoing development of cutting-edge technologies in biological filtering.

Conclusion

Hadar Amartely's work exemplifies the intersection of innovation and healthcare, showcasing the importance of developing advanced technologies for medical applications. His contributions to biological filtering are paving the way for new treatment options for patients with autoimmune diseases and cancer.